Wayne Winegarden
Commentary
Reducing Access To Home Healthcare Services Will Raise Costs And Worsen Outcomes
The Centers for Medicare and Medicaid Services (CMS) recent decision on home healthcare services, if implemented, will increase overall healthcare expenditures and decrease the quality of services received by patients. CMS’ overarching goal is praiseworthy – the agency is trying to maintain budget neutrality while changing its payment system rates. ...
Blog
Replacing White Bagging Mandates With Market Competition Will Improve Patient Outcome
Pharmacy benefit managers (PBMs) deploy numerous anticompetitive actions, which have not gone unnoticed. The Federal Trade Commission (FTC) has launched an inquiry to examine whether PBMs have adverse impacts “on the access and affordability of prescription drugs.” The government’s probe is welcome news. But there are many detrimental PBM practices that are ...
Featured
NEW BRIEF: Biosimilars Save Patients Over $11 Billion Annually, Fixing Broken System Would Help Patients Save More
SACRAMENTO – Biosimilars competition saves patients and the health care system over $11 billion annually and could generate even more savings if the broken drug pricing system were reformed, finds a new issue brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Business & Economics
The High Cost Of The Inflation Reduction Act
The right policy mix to address our current economic malaise is tighter monetary policy and pro-growth tax and regulatory policies. While the Federal Reserve is on the right track for monetary policy, the newly titled Inflation Reduction Act is completely wrongheaded. The tax provisions – such as imposing a minimum corporate tax ...
California
Wayne Winegarden Talks California’s Project Homekey on Andy Caldwell Show
PRI’s Wayne Winegarden discusses California’s Project Homekey and his new study from Kerry Jackson and himself, “Project Homekey Provides No Way Home for California’s Homeless,” on the Andy Caldwell Show.
Business & Economics
Proxy Advisory Firms And The ESG Risk
Warren Buffett presciently noted that “only when the tide goes out do you discover who’s been swimming naked.” The Dow, S&P 500, and Nasdaq are all now in bear market territory, so the tide has undoubtedly receded. And true to Mr. Buffett’s wisdom, the unsustainability of many fashionable investment trends ...
Blog
Drug Price Controls Are Not the Solution to Another Bad Inflation Report
The July 13th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious. ...
Commentary
California’s climate lawsuits threaten to raise energy prices and harm consumers
The recent Supreme Court ruling in West Virginia v. EPA reinforced the commonsense notion that it is the responsibility of our elected representatives, not the courts, to establish our nation’s global climate change policies. If only the states and localities suing the global energy companies, many of which are here ...
Business & Economics
Wayne Winegarden Talks Consumer Spending, Housing Market Trends with Nasdaq Trade Talks
Dr. Wayne Winegarden, PRI senior fellow in business and economics, discusses how macro factors are impacting the housing market and consumer spending with host Jill Malandrino on “Nasdaq Trade Talks”.
Featured
Wayne Winegarden Plan to Let Medicare Negotiate Drug Prices on Scripps National News
In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient costs compared to a plan working its way through Congress to let Medicare negotiate prescription drug prices. ...
Reducing Access To Home Healthcare Services Will Raise Costs And Worsen Outcomes
The Centers for Medicare and Medicaid Services (CMS) recent decision on home healthcare services, if implemented, will increase overall healthcare expenditures and decrease the quality of services received by patients. CMS’ overarching goal is praiseworthy – the agency is trying to maintain budget neutrality while changing its payment system rates. ...
Replacing White Bagging Mandates With Market Competition Will Improve Patient Outcome
Pharmacy benefit managers (PBMs) deploy numerous anticompetitive actions, which have not gone unnoticed. The Federal Trade Commission (FTC) has launched an inquiry to examine whether PBMs have adverse impacts “on the access and affordability of prescription drugs.” The government’s probe is welcome news. But there are many detrimental PBM practices that are ...
NEW BRIEF: Biosimilars Save Patients Over $11 Billion Annually, Fixing Broken System Would Help Patients Save More
SACRAMENTO – Biosimilars competition saves patients and the health care system over $11 billion annually and could generate even more savings if the broken drug pricing system were reformed, finds a new issue brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
The High Cost Of The Inflation Reduction Act
The right policy mix to address our current economic malaise is tighter monetary policy and pro-growth tax and regulatory policies. While the Federal Reserve is on the right track for monetary policy, the newly titled Inflation Reduction Act is completely wrongheaded. The tax provisions – such as imposing a minimum corporate tax ...
Wayne Winegarden Talks California’s Project Homekey on Andy Caldwell Show
PRI’s Wayne Winegarden discusses California’s Project Homekey and his new study from Kerry Jackson and himself, “Project Homekey Provides No Way Home for California’s Homeless,” on the Andy Caldwell Show.
Proxy Advisory Firms And The ESG Risk
Warren Buffett presciently noted that “only when the tide goes out do you discover who’s been swimming naked.” The Dow, S&P 500, and Nasdaq are all now in bear market territory, so the tide has undoubtedly receded. And true to Mr. Buffett’s wisdom, the unsustainability of many fashionable investment trends ...
Drug Price Controls Are Not the Solution to Another Bad Inflation Report
The July 13th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious. ...
California’s climate lawsuits threaten to raise energy prices and harm consumers
The recent Supreme Court ruling in West Virginia v. EPA reinforced the commonsense notion that it is the responsibility of our elected representatives, not the courts, to establish our nation’s global climate change policies. If only the states and localities suing the global energy companies, many of which are here ...
Wayne Winegarden Talks Consumer Spending, Housing Market Trends with Nasdaq Trade Talks
Dr. Wayne Winegarden, PRI senior fellow in business and economics, discusses how macro factors are impacting the housing market and consumer spending with host Jill Malandrino on “Nasdaq Trade Talks”.
Wayne Winegarden Plan to Let Medicare Negotiate Drug Prices on Scripps National News
In a national TV interview with Scripps National News, Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, says making drug rebates work for patients would more effectively lower patient costs compared to a plan working its way through Congress to let Medicare negotiate prescription drug prices. ...
